Send us message to learn more about InnoHK
CONTACT US
Alzheimer’s Disease

Hong Kong Center for Neurodegenerative Diseases

Hong Kong Center for Neurodegenerative Diseases

Developing Effective Therapeutics for Alzheimer’s Disease via a Rapid Bench-to-Bedside Model

Together with our collaborators from different parts of the world, we will draw leading scientists in the field to conduct cutting-edge research at the Center. The InnoHK initiative provides an important enabling platform for the Center to facilitate multi-disciplinary and cross-institutional collaborations to further advance knowledge in the early detection and therapeutic treatment of Alzheimer’s disease.
Professor Nancy IP

The Morningside Professor of Life Science, and Director of the State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology

Developing Effective Therapeutics for Alzheimer’s Disease via a Rapid Bench-to-Bedside Model

Alzheimer's disease (AD), a chronic neurodegenerative disease, of which cause is not fully understood, is a growing global health challenge with significant social and economic consequences. Researchers from the State Key Laboratory of Molecular Neuroscience at the Hong Kong University of Science and Technology (HKUST) have made important progress in understanding the complex pathophysiology of neurodegenerative diseases including AD. The innovative methodologies and advanced technologies these researchers use are driving efforts to decipher the complex biological processes underlying AD.

Led by prominent scientists from HKUST, HKCeND is aimed to establish a collaborative scientific hub for neurodegenerative disease research center in Hong Kong.

Led by prominent scientists from HKUST, HKCeND is aimed to establish a collaborative scientific hub for neurodegenerative disease research center in Hong Kong.

A glimpse of our enthusiastic and devoted young researchers working in laboratory.

A glimpse of our enthusiastic and devoted young researchers working in laboratory.

Our laboratories are designed and built to accommodate R&D facilities specific to neuroscience technologies.

Our laboratories are designed and built to accommodate R&D facilities specific to neuroscience technologies.

Building on the pioneering work of HKUST researchers, Hong Kong Center for Neurodegenerative Diseases has been established with a mission to build a hub for advanced research in neurodegenerative diseases in Hong Kong, in particular, to find a cure for AD. As the disease is not only a neuro-centric disorder, but also affected by other factors such as the immune system, the Center is paving the way to identify biomarkers in peripheral systems, as well as therapeutic targets in the immune system for drug development.

The Center has embarked on three interrelated research programmes to:

  • Develop novel biomarkers using an integrative approach
  • Investigate therapeutic targets and pathways in AD
  • Identify systemic factors for AD treatment

The overarching goal of these programmes is to establish technological platforms, patient bioinformatics data, and induced pluripotent stem cell (iPSC) repositories to form a pipeline to develop effective therapeutics via a rapid bench-to-bedside model. New findings with high commercial potential, such as novel therapeutic targets and candidates for drug discovery and biomarker panels for disease prognosis and diagnosis, as well as personalised medicine will be developed.

Collaborative alliances will be sought with industry partners in the Greater Bay Area and other regions in mainland China to facilitate translational and preclinical development. The Center will also contribute to local talent development by creating new career and training opportunities for students, researchers, and scientists.

Project team members

  • HKCeND
    HKCeND

    -

  • NI
    Professor Nancy Ip

    Center Director

In this project

You may also like

Neuromusculoskeletal
Center for Neuromusculoskeletal Restorative Medicine (CNRM)
Center for Neuromusculoskeletal Restorative Medicine (CNRM)
The initiatives for setting up the CNRM, with its thematic & multi- disciplinary nature and collaboration between the two world-class research institutions, present a very unique strength to accelerate R&D breakthrough in neuromusculoskeletal disease. It will certainly strengthen the stature and commitment of Hong Kong as an advanced R&D hub in the region.

OUR TEAM

Professor Patrick Yung, Professor Woody Chan
Center for Neuromusculoskeletal Restorative Medicine (CNRM)
Biomedical
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
We will recruit top-notch talent locally, from Mainland China, as well as from overseas thanks to the international environment and unique legal system in Hong Kong. To connect with the renowned biomedical institutions and hospitals in the region, we aim to conduct world-class, cutting-edge collaborative biomedical research.

OUR TEAM

Professor Duanqing Pei , Professor Guangjin Pan
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
Microbiome
Microbiota I-Center (MagIC)
Microbiota I-Center (MagIC)
The Microbiota I-Center (MagIC) is determined to harness and empower microbiome into cutting-edge innovations that will transform lives of patients and their families. We are committed to developing novel classes of microbiome diagnostics and therapeutics that will accelerate Hong Kong into a world-class microbiome biotechnology hub.

OUR TEAM

Professor Siew C. Ng, Professor Francis Chan
Microbiota I-Center (MagIC)
Stem Cell
Centre for Translational Stem Cell Biology
Centre for Translational Stem Cell Biology
Hong Kong is a ‘meeting point’ for global tech-savvy talent. Its close proximity to cities in the Greater Bay Area makes it the ideal location for advanced stem cell research. At CTSCB, we aim to develop world-leading new technologies and products that address unmet clinical needs in regenerative medicine, organ transplantation, and genomic medicine, which will place Hong Kong at the global forefront in innovation and technology development.

OUR TEAM

Professor Pengtao Liu, CTSCB
Centre for Translational Stem Cell Biology

Find your interest